A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Govt to look at how to get baby-boomers to move home
Fire mayor faces tough questions
Switzerland tops quality of life survey
The 10 million initiative could have unique impact on Geneva
Two priests suspended in Biel
Hunt underway for internationally wanted prisoner
